Top

A Year of Growth and Gratitude – A Message from the EBMT President

… unwavering commitment to saving the lives of patients with blood cancers and other life-threatening diseases. Your efforts continue to push the boundaries of … a few scientific partners, furthering the fight against blood disorders on a global scale. Looking Ahead to 2025 As …

Low Body Mass Index Is Associated with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute Leukemia: A Study on Behalf of Eurocord and the EBMT Paediatric Diseases Working Party.

… with Increased Risk of Acute GVHD after Umbilical Cord Blood Transplantation in Children and Young Adults with Acute … A Study on Behalf of Eurocord and the EBMT Paediatric Diseases Working Party. …

Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation.

… A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation. …

Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT).

… acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT). …

Publications

… Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.      Tichelli A … Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT) Pilot study using … stem cell transplantation (HSCT) for severe autoimmune diseases (ADs): A position statement from the EBMT Autoimmune …

Summary of recent EBMT publications

… stem cell transplantation for haematological diseases, solid tumours and immune disorders: current … Kröger, Mohamad Mohty, for the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow … alongside the MACRO registry.   The European Society for Blood and Marrow Transplantation (EBMT) consensus …

My paper of the month - Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis

… (ATG) 7 , and sirolimus 8 in malignant and non-malignant diseases, in both adult and pediatric populations 9 In this … and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2008 Jun;14(6):641-50. doi: … with posttransplant cyclophosphamide-based prophylaxis. Blood. 2021 Jul 22;138(3):273-282. doi: …

EBMT Celebrates European Myeloma Day

… surrounding access to them. The CMWP Plasma Cell Diseases (PCD) subcommittee has long been focused on … the continuing role of high dose melphalan with peripheral blood stem cell support in the treatment of younger, fitter …

EBMT 2022 Annual Meeting - 1st Trainee Day

… manipulated or unmanipulated haematopoietic cells to treat diseases. While initially dedicated to the treatment of … its efficacy is currently being investigated in several diseases and cancers. “Indications are currently booming,” … and Cellular Therapy (ASTCT) and European Society for Blood and Marrow Transplantation (EBMT) have highlighted the …

World MS Day: How Stem Cell Transplantation is Changing the Future of Multiple Sclerosis

… Tobias Alexander, Secretary and Chair of the Autoimmune Diseases Working Party (ADWP) and Gavin Brittain, member of … system. The process involves collecting a patient’s own blood stem cells, followed by chemotherapy to remove the … target the harmful immune cells involved in autoimmune diseases, potentially offering new options for people whose …